GP2013 in the Treatment of RA Patients Refractory to or Intolerant of Standard Therapy
Public ClinicalTrials.gov record NCT01274182. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Controlled Study to Evaluate PK, PD, Safety and Efficacy of GP2013 and Rituximab in Patients With Rheumatoid Arthritis Refractory or Intolerant to Standard DMARDs and up to Three Anti-TNF Therapies.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine the PK/PD, efficacy and safety of GP2013 in patients with severe rheumatoid arthritis.
Study identification
- NCT ID
- NCT01274182
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Enrollment
- 312 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 2011 (Type not available)
- Primary completion
- Jan 2016 (Actual)
- Completion
- Nov 2016 (Actual)
- Last update posted
- Jan 24, 2018
2011 – 2016
United States locations
- U.S. sites
- 16
- U.S. states
- 14
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Miller Clinical Research | Los Angeles | California | 90057 | — |
| Bluegrass Community Research, Inc. | Lexington | Kentucky | 40504 | — |
| Klein & Associates | Cumberland | Maryland | 21502 | — |
| Klein & Associates | Hagerstown | Maryland | 21740 | — |
| Clinical Pharmacology Study Group | Worcester | Massachusetts | 01605 | — |
| Physician Research Collaboration, LLC | Lincoln | Nebraska | 68516 | — |
| Innovative Health Research | Las Vegas | Nevada | 89128 | — |
| DJL Clinical Research PLLC | Charlotte | North Carolina | 28210 | — |
| Health Research of Oklahoma | Oklahoma City | Oklahoma | 73103 | — |
| Altoona Center for Clinical Research | Duncansville | Pennsylvania | 16635 | — |
| Clinical Research Center of Reading LLC | Wyomissing | Pennsylvania | 19610 | — |
| Low Country Rheumatology, PA | Charleston | South Carolina | 29406 | — |
| Regional Health Clinical Research | Rapid City | South Dakota | — | — |
| West Tennessee Research Institute | Jackson | Tennessee | 38305 | — |
| Arthritis & Osteoporosis Center of South Texas | San Antonio | Texas | 78232 | — |
| The Seattle Arthritis Center | Seattle | Washington | 98133 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 41 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01274182, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 24, 2018 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01274182 live on ClinicalTrials.gov.